Pfizer reported a decline in fourth-quarter sales Tuesday, pointing to headwinds of a stronger dollar and competition from generic drugs as more patents expire, issues it says aren't likely to abate this year. Revenue fell 3% to $13.1 billion, but beat Wall Street consensus estimates of $12.9 billion. Profit was $1.2 billion, [...]
Similar Stories to Pfizer Sales Suffer From Patent Losses, Stronger Dollar on Bing News
Lauren Gensler, Forbes Staff, Forbes
Tue, 01/27/2015 - 6:39am
BING NEWS:
- Pfizer's Doldrums, Just A Bad Case Of COVID-19?
Pfizer may be worth buying as the COVID-based product revenues decline and equilibrate. Click here to read why I'm bullish on PFE stock.
04/16/2024 - 2:15 am | View Link - Pfizer wins pause on Moderna's COVID-19 patent lawsuit
Sales of both vaccines declined significantly last year from 2022. Defendants frequently turn to the U.S. Patent Office's Patent Trial and Appeal Board, which reconsiders the validity of patents ...
04/12/2024 - 9:42 am | View Link - Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
"The company is facing a number of challenges, but we believe the event was a success in laying out a path for the oncology business to help offset upcoming patent losses, and drive growth in the ...
03/10/2024 - 12:48 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more